KIF3C inhibits the progression and proliferation of colorectal cancer
BMC Gastroenterology · 2025
DOI: 10.1186/s12876-024-03489-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Gastroenterology, 2025. Verfasst von Maladho Tanta Diallo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China. Hauptthemen laut MEDLINE: Kinesins, Colorectal Neoplasms, Cell Proliferation. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China.
- General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou, 225001, China.
- Medical College of Yangzhou University, Yangzhou, 225001, China.
- Yangzhou Key Laboratory of Basic and Clinical Transformation of Digestive and Metabolic Diseases, Yangzhou, 225001, China.
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, 225001, China. wangdaorong@nju.edu.cn.
- General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou, 225001, China. wangdaorong@nju.edu.cn.
Zitieren
APA
Diallo, M. T., Chen, B., Yao, Q., Yan, Z., Sun, Q., & Wang, D. (2025). KIF3C inhibits the progression and proliferation of colorectal cancer. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03489-0
Vancouver
Diallo MT, Chen B, Yao Q, Yan Z, Sun Q, Wang D. KIF3C inhibits the progression and proliferation of colorectal cancer. BMC Gastroenterology. 2025. doi:10.1186/s12876-024-03489-0
BibTeX
@article{Diallo2025,
author = {Diallo, Maladho Tanta and Chen, Bangquan and Yao, Qing and Yan, Zhang and Sun, Qiannan and Wang, Daorong},
title = {KIF3C inhibits the progression and proliferation of colorectal cancer},
journal = {BMC Gastroenterology},
year = {2025},
doi = {10.1186/s12876-024-03489-0}
}
EUVIMED